Alan J. Wolfe Ph.D.,  Microbiology & Immunology, Loyola University Chicago

 
Overview of Research

Projects

People

Publications

Protocols

Photos

Alumni

Dr. Wolfe's courses

 

 

 

 

 

 

Signal transduction networks and the control of gene expression

Networks of signaling pathways permit cells to sense and respond to their changing environment. Some of these signaling pathways produce small molecules, called second messengers, that mediate a wide range of cellular responses. These include cyclic AMP (cAMP) and cyclic di-GMP (c-di-GMP). Other signaling pathways do not produce small molecules but, instead, respond to them. For example, certain members of the family of two-component signal transduction (2CST) pathways respond to the small molecule acetyl phosphate (acetyl-P). In the Wolfe lab, we study the impact of all three of these small molecules.

The well-studied cAMP binds to a transcription factor called CRP (also known as CAP), permitting it to bind to DNA and activate the transcription of hundreds of genes. One of those genes is acs, which encodes acetyl-CoA synthetase (Acs), the enzyme that converts free acetate into acetyl-CoA. In humans, Acs re-activates the acetate stripped from acetylated histones, removed from acetylcholine, or derived by the metabolism of the ethanol I drank last night. In bacteria, like Escherichia coli, it performs a critical survival function, scavenging for small amounts of acetate in the environment during periods of carbon starvation. The critical role of Acs requires exquisite regulation, especially at the level of transcription initiation. In an effort to understand how cells control the function of RNA polymerase, the bio-machine responsible for transcription, we have been dissecting the sophisticated circuitry that regulates acs transcription.

The newly recognized c-di-GMP has been implicated in the transition between the motile/planktonic and sessile/biofilm lifestyles of diverse bacteria, including diverse pathogens. Many bacteria possess dozens of genes implicated in the synthesis and degradation of c-di-GMP, suggesting that they produce c-di-GMP for use in multiple pathways, presumably in response to unique stimuli. In most cases, however, the identity of c-di-GMP targets and the mechanisms by which this molecule identifies and acts upon those targets remain unknown. Also poorly understood are the mechanisms by which the levels and/or localization of c-di-GMP are regulated. In close collaboration with my colleague and neighbor Dr. Karen Visick, we have gained valuable insights into the control of c-di-GMP production and its targets while investigating the motility of the marine bacterium, Vibrio fischeri.

Acetyl-P (derived directly from acetyl-CoA) has been reported to act as a global signal with the capacity to donate phosphoryl groups directly to a subset of 2CST regulators (RRs). Previously, we employed DNA array technology to demonstrate that acetyl-P influences the transcription of nearly 100 genes. More recently, through a series of epistasis experiments, we showed that acetyl-P acts through RcsB, a global RR effecting transitions between the motile and sessile lifestyles. Currently, we are completing studies that support the hypothesis that acetyl-P affects transcription by directly donating its phosphoryl group to RRs such as RcsB. Taken together, these observations establish a connection between central metabolism and cell signaling mediated by acetyl-P. Future studies include mapping the impact of acetyl-P on the entire network of 2CST pathways, learning how cells regulate the levels of acetyl-P, and developing new assays to monitor acetyl-P, especially in pathogens with stringent growth conditions.